Market closed
BioCryst/$BCRX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About BioCryst
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Ticker
$BCRX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
536
Website
BioCryst Metrics
BasicAdvanced
$1.5B
Market cap
-
P/E ratio
-$0.60
EPS
1.89
Beta
-
Dividend rate
Price and volume
Market cap
$1.5B
Beta
1.89
52-week high
$8.84
52-week low
$4.03
Average daily volume
2.2M
Financial strength
Current ratio
2.781
Quick ratio
2.621
Long term debt to equity
-172.069
Total debt to equity
-179.728
Interest coverage (TTM)
-0.35%
Management effectiveness
Return on assets (TTM)
-4.25%
Return on equity (TTM)
28.15%
Valuation
Price to revenue (TTM)
3.631
Price to book
-3.17
Price to tangible book (TTM)
-3.17
Price to free cash flow (TTM)
-26.409
Growth
Revenue change (TTM)
29.92%
Earnings per share change (TTM)
-51.87%
3-year revenue growth (CAGR)
53.52%
3-year earnings per share growth (CAGR)
-22.08%
What the Analysts think about BioCryst
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for BioCryst stock.
BioCryst Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
BioCryst Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
BioCryst News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for BioCryst stock?
BioCryst (BCRX) has a market cap of $1.5B as of November 22, 2024.
What is the P/E ratio for BioCryst stock?
The price to earnings (P/E) ratio for BioCryst (BCRX) stock is 0 as of November 22, 2024.
Does BioCryst stock pay dividends?
No, BioCryst (BCRX) stock does not pay dividends to its shareholders as of November 22, 2024.
When is the next BioCryst dividend payment date?
BioCryst (BCRX) stock does not pay dividends to its shareholders.
What is the beta indicator for BioCryst?
BioCryst (BCRX) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.